Company Filing History:
9 out of 14 
2 out of 447 
1 out of 5 Years Active: 1996-2024
Title: Innovations of Inventor Wah Yau Wong
Introduction
Wah Yau Wong is a notable inventor based in Edmonton, Canada. With an impressive portfolio of 14 patents, he is recognized for his significant contributions to the field of cancer research and immunotherapy.
Latest Patents
Wong's latest patents showcase innovative methods and compositions aimed at restoring the function of tumor-acidified T cells. One patent describes a method involving the administration of urease to these T cells, enhancing their ability to combat cancer. Another notable patent involves pharmaceutical compositions comprising antibody-urease conjugates, which are prepared without the need for chromatographic purification. These compositions are designed for antibody-directed enzyme prodrug therapy, where urease converts endogenous urea into ammonia in situ, inducing cytotoxicity against cancer cells.
Career Highlights
Throughout his career, Wong has worked with reputable organizations, notably Helix Biopharma Corporation and the University of Alberta. His research and development efforts at these institutions have played a pivotal role in advancing therapeutic strategies in oncology.
Collaborations
Wong has collaborated with esteemed colleagues including Baomin Tian and Heman Chao. Their teamwork reflects a strong dedication to fostering innovation and pushing the boundaries of cancer treatment methodologies.
Conclusion
Wah Yau Wong's contributions to patentable innovations in cancer therapy underline his importance in the scientific community. His latest patents and collaborations highlight a relentless pursuit of new solutions to complex medical challenges. With 14 patents to his name, Wong continues to impact the field significantly, showcasing the power of innovation in enhancing patient outcomes in oncology.